A decision framework for COOs weighing native tools, custom builds, and AI agents

Should a practice build refill automation in-house or buy an AI refill agent?

TL;DR: Most practices should buy an AI refill agent rather than build one in-house, unless they have an engineering team and a stable, narrow use case. EHR-native tools handle simple renewals but leave chart review and exceptions manual. In-house builds are fragile and expensive to maintain, while purpose-built agents trade a subscription cost for faster deployment, ongoing upkeep, and audit trails. The right answer depends on volume, IT capacity, and how many EHRs you run.

Build versus buy is the first question a COO or practice administrator asks when refill volume gets out of hand. Your EHR has some automation. Your IT contractor says they can script something. A vendor says their AI agent solves it in weeks. All three can work, and all three can fail.

This article gives you a framework for deciding whether to build refill automation in-house or buy an AI refill agent: the three options, the criteria that matter, the real costs, and the situations where each choice makes sense.

What are your three options for refill automation?

Practices usually weigh three paths, whether they name them or not.

EHR-native tools. Most EHRs include some refill workflow: a renewal inbox, templates, task routing, and sometimes rules that auto-route requests to a provider. These tools are included in what you already pay for, and they're a reasonable first step.

In-house build. Your team, a contractor, or an internal developer writes scripts, robotic process automation (RPA), or integrations that read refill requests and prepare responses. It's tailored to your workflow and owned by you.

Purpose-built AI agent. A vendor provides an agent trained for refill work that connects to your EHR, applies your protocols, drafts renewals, and handles responses. You pay a subscription and the vendor maintains it.

The question isn't which is best in the abstract. It's which fits your volume, your systems, and the people you actually have.

Where do EHR-native tools fall short?

Native tools are built to be general. They give you the pieces of a refill workflow, but they rarely do the thinking between the pieces.

A native inbox will show a provider a renewal request. It usually won't compare the request to your protocol, check the visit date and last fill, flag an early refill, draft a message telling the patient to book, and close the loop with the pharmacy. A person does those steps, and that person's time is the cost you're trying to remove.

Native tools also tend to cover requests that arrive electronically in the format the EHR expects. Faxed renewals, free-text portal messages, and phone notes often fall outside that path and get handled by hand.

If your volume is low and your requests are mostly structured pharmacy renewals, native tools may be enough. Be honest about that before spending money elsewhere. When volume grows or the mix gets messy, the gap shows up in staff hours.

What does an in-house build really cost?

Building looks cheap at the start because the first version is cheap. A script that reads a request and pulls a few chart fields can come together quickly. The cost shows up later.

Consider what an in-house refill build has to handle over time:

  • EHR changes. Vendors update screens, APIs, and data formats. Scripts that depend on them break, often silently.
  • Input variety. Pharmacy formats, portal wording, fax layouts, and misspelled names all need handling, and the long tail never ends.
  • Protocol updates. Every time your providers change a rule, someone has to change the logic and test it.
  • Exceptions. The hard cases are most of the work. A build that handles 70 percent of requests still leaves your team with a messy 30 percent and no clear way to see why.
  • Ownership. If the person who built it leaves, you own a system nobody understands.

RPA in particular is known for being brittle when screens change, because it often works by mimicking clicks. If your EHR has a reliable API and you have a developer who will maintain the project, a build can work. If it depends on one contractor, treat it as a risk.

The honest cost of building is the first version plus years of maintenance, monitoring, and rework. Put a number on the developer time before you compare it to a subscription.

What do you get from buying a purpose-built agent?

A purpose-built agent shifts the maintenance burden to a vendor whose whole business is keeping the workflow working. The tradeoffs look like this.

Time to deploy. A vendor that has already built integrations for common EHRs can usually get you running faster than a ground-up build. You still need to write your protocols, which takes time regardless of the path.

Coverage of inputs. An agent built for the job is designed for the messy cases: faxes, portal free text, mismatched names, and varied pharmacy formats.

Upkeep. When an EHR changes, the vendor adjusts. When payer or pharmacy formats shift, the vendor adjusts. That ongoing work is part of what you're paying for.

Audit trail. A good agent logs what it read, what it checked, and why it routed a request a certain way. That record matters for compliance and for debugging.

Cost structure. You pay a recurring fee instead of a development bill, which makes the cost predictable but permanent.

Honey Health is one example of this category. Its refill management agent works alongside the EHR to handle intake, protocol checks, draft renewals, and responses, with the provider keeping the final signature. Judge any vendor, Honey Health included, against the same criteria below.

How do you compare the options? A decision framework

Score each path against these six criteria. Weight them by what matters to your practice.

  1. Total cost of ownership. Add the subscription or build cost, plus maintenance, plus staff time on exceptions, over three years.
  2. Time to value. How long until the first lane is running and saving hours?
  3. EHR integration depth. Does the option read charts and write drafts reliably, and what happens when the EHR updates? If you run more than one EHR across locations, this matters even more.
  4. Compliance and audit. Can you see what happened to every request? Is a business associate agreement in place, and does the vendor follow HIPAA security requirements? The HHS HIPAA Security Rule guidance is the reference point for what any tool touching patient data must support.
  5. Exception handling. Who owns the requests the automation can't resolve, and how clearly are they surfaced?
  6. Flexibility. Can you change protocols without a developer?

A quick pattern holds across most practices. Low volume and simple requests favor native tools. A strong internal engineering team with a narrow, stable need can justify a build. Mid-to-large practices, multi-specialty groups, and MSOs with several locations and mixed EHRs usually find a purpose-built agent cheaper once maintenance is counted.

When is building or staying native the right call?

Buying isn't always correct, and any vendor who says otherwise is selling.

Stay with native tools when your refill volume is modest, your requests mostly arrive in structured electronic form, and your staff keeps up without strain. Adding a vendor would cost more than the problem.

Build when you have developers who will own the project long term, your workflow is narrow and stable, you run a single EHR with a dependable API, and you want complete control over the logic. Plan for monitoring and a maintenance budget from day one.

Buy when volume is high, your input channels are mixed, you operate across multiple locations or EHRs, you lack engineering capacity, or you need audit logs and vendor accountability. For most mid-to-large independent practices, multi-specialty groups, and PE-backed MSOs, this is where the numbers land.

You can also combine paths. Use native tools for the simple structured renewals and an agent for the messy remainder. That keeps costs down while still removing the hard manual work.

How should you run the decision?

Don't decide from a demo or a quote alone. A short process keeps the choice grounded.

  1. Time ten refills and calculate your current monthly cost in staff hours.
  2. Sort a month of requests by channel to see how much is structured versus messy.
  3. Write your protocols, since every path needs them.
  4. Ask each option the same questions: integration method, exception handling, audit logging, security posture, and what happens when your EHR updates.
  5. Pilot a single lane before committing broadly.

Whatever you pick, keep providers as the signer on every renewal and keep controlled substances in human hands. That part doesn't change with the technology.

What about Tebra and other mid-market EHRs?

Practices on mid-market EHRs often assume purpose-built tools only work with the largest systems. That assumption is worth testing. Ask any vendor, in writing, which integration method they use for your EHR: a direct API, a partner connection, or screen-level automation. Each has different reliability and maintenance implications.

Also ask what happens at the edges. A refill request that arrives by fax from a pharmacy, a portal message that names the wrong dose, and a phone note with a misspelled patient name are the cases that separate a demo from a deployment. Request a pilot on your own messy requests, not a vendor's clean sample.

Finally, check how the option handles several locations. A group with three sites and two EHRs needs a consistent protocol across all of them, and that's much easier to maintain in one managed system than in three separate scripts.

Frequently Asked Questions

Is it cheaper to build refill automation in-house?

It's cheaper to start and often more expensive to keep. The first script is inexpensive, but EHR changes, new input formats, protocol updates, and exception handling create ongoing developer costs. Compare three-year total cost, not just the first version.

Can my EHR's built-in tools handle refills on their own?

For structured electronic renewals at modest volume, often yes. Native tools usually don't check your protocol, draft the response, or handle faxes and free-text messages, so staff still do that work by hand.

What is the biggest risk of RPA for refills?

Brittleness. RPA often mimics clicks on screens, so interface updates can break it without warning. If you build with RPA, plan monitoring and fast repair, or prefer a direct API integration.

What should I ask a vendor before buying an AI refill agent?

Ask how it integrates with your EHR, how it handles faxes and free-text requests, what it logs for audit, how it treats controlled substances, whether it signs a business associate agreement, and who supports it when something breaks.

Do I still need providers if I buy an AI agent?

Yes. The agent prepares and routes work, and providers approve renewals. Controlled substances and clinical exceptions should always go to a clinician.

More of our Article
CLINIC TYPE
LOCATION
INTEGRATIONS
More of our Article and Stories